Furthermore, in this study the authors develop a small-molecule inhibitor of ENPP1 (ectonucleotide pyrophosphatase phosphodiesterase 1), the endogenous cGAMP hydrolase, that when delivered increases extracellular cGAMP concentrations and enhances the efficacy of radiotherapy in pre-clinical mouse models of breast cancer. Here, ENPP1 is linked to breast cancer.